Yoo; Seok Ho

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoo; Seok Ho.The latest application filed is for "bispecific antibody specifically binding to il-17a and tnf-alpha".

Company Profile

3.8.12

Yoo; Seok Ho - Daejeon KR
Yoo; Seok Ho - Yuseong-gu KR
Yoo; Seok Ho - Seo-gu Daejeon KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody against human DLK1 and use thereof Grant 11,306,141 - Lim , et al. April 19, 2	2022-04-19
BISPECIFIC ANTIBODY SPECIFICALLY BINDING TO IL-17A AND TNF-Alpha App 20220098297 - YOON; Jae Bong ; et al.	2022-03-31
Monoclonal Antibody Specifically Binding To Lag-3 And Use Thereof App 20210238283 - LEE; Sang Pil ; et al.	2021-08-05
Antibody Against Human DLK1 and Use Thereof App 20210214432 - Lim; Jung Chae ; et al.	2021-07-15
Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog Grant 10,448,662 - Park , et al. Oc	2019-10-22
Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof Grant 10,259,850 - Ha , et al.	2019-04-16
Anti-TNF-.alpha./CXCL10 double-targeting antibody and use thereof Grant 10,087,248 - Kang , et al. October 2, 2	2018-10-02
Modified Dkk2 Protein, Nucleic Acid Encoding The Same, Preparation Method Thereof, And Use Thereof App 20180016313 - HA; Il Ho ; et al.	2018-01-18
Composition for Preventing or Treating Fatty Liver or Insulin Resistance Syndrome Including Extracellular Domain of Delta-Like 1 Homolog App 20170121380 - Park; Young Woo ; et al.	2017-05-04
Anti-c-Met antibody having HGF activity and use thereof Grant 9,631,020 - Park , et al. April 25, 2	2017-04-25
Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredient Grant 9,388,223 - Lee , et al. July 12, 2	2016-07-12
Drug conjugate comprising drug linked to human c-Met antibody, and use therefor Grant 9,364,556 - Park , et al. June 14, 2	2016-06-14
Anti-TNF-alpha/CXCL10 Double-Targeting Antibody and Use Thereof App 20160108118 - Kang; Heun-Soo ; et al.	2016-04-21
Drug Conjugate Comprising Drug Linked To Human C-met Antibody, And Use Therefor App 20150110815 - Park; Young Woo ; et al.	2015-04-23
Myostatin Inhibitor Comprising Extracellular Water-Soluble Domains of DLK1 As Active Ingredient App 20150030595 - Lee; Dong Hee ; et al.	2015-01-29
Anti-c-met Antibody Having Hgf Activity And Use Thereof App 20140193431 - Park; Young Woo ; et al.	2014-07-10
Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain App 20140072558 - Park; Young Woo ; et al.	2014-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.